Bioverativ Inc. is an American multinational biotechnology, specializing in the discovery, development, and delivery of therapies for the treatment of haemophilia. Bioverativ competes with Baxalta (acquired by Shire Plc in 2016), Pfizer and Novo Nordisk. The company trades on the NASDAQ exchange under the ticker symbol BIVV. - Source: Wikipedia